Assetmark, Inc Dexcom Inc Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Dexcom Inc stock. As of the latest transaction made, Assetmark, Inc holds 39,731 shares of DXCM stock, worth $3.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,731

Previous 41,014 3.13%

Holding current value

$3.19 Million

Previous $4.65 Million 42.75%

% of portfolio

0.01%

Previous 0.01%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$64.0 - $116.06 $82,112 - $148,904	-1,283 Reduced 3.13%	39,731 $2.66 Million
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $159,067 - $202,528	1,442 Added 3.64%	41,014 $4.65 Million
Q1 2024 May 06, 2024	BUY	$114.22 - $140.1 $100,627 - $123,428	881 Added 2.28%	39,572 $5.49 Million
Q4 2023 Feb 09, 2024	SELL	$75.49 - $124.16 $562,325 - $924,867	-7,449 Reduced 16.14%	38,691 $4.8 Million
Q3 2023 Oct 27, 2023	BUY	$86.06 - $137.93 $269,539 - $431,996	3,132 Added 7.28%	46,140 $4.3 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $420,637 - $489,865	3,740 Added 9.52%	43,008 $5.53 Million
Q1 2023 May 05, 2023	SELL	$104.0 - $122.92 $284,232 - $335,940	-2,733 Reduced 6.51%	39,268 $4.56 Million
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $199,703 - $288,274	2,350 Added 5.93%	42,001 $4.76 Million
Q3 2022 Nov 01, 2022	SELL	$76.35 - $94.18 $85,130 - $105,010	-1,115 Reduced 2.74%	39,651 $3.19 Million
Q2 2022 Aug 03, 2022	BUY	$67.99 - $132.89 $2.16 Million - $4.21 Million	31,708 Added 350.06%	40,766 $3.04 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $441,423 - $610,898	4,692 Added 107.47%	9,058 $4.63 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $517,791 - $649,163	3,987 Added 1051.98%	4,366 $2.34 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $21,555 - $28,922	202 Added 114.12%	379 $207,000
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $24,377 - $32,486	-301 Reduced 62.97%	177 $76,000
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $3,900 - $4,818	-46 Reduced 8.78%	478 $172,000
Q4 2020 Feb 10, 2021	SELL	$78.0 - $104.5 $10,452 - $14,003	-134 Reduced 20.36%	524 $194,000
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $2,769 - $3,275	-29 Reduced 4.22%	658 $271,000
Q2 2020 Aug 11, 2020	BUY	$62.68 - $105.34 $34,975 - $58,779	558 Added 432.56%	687 $279,000
Q1 2020 May 12, 2020	SELL	$47.79 - $75.63 $621 - $983	-13 Reduced 9.15%	129 $35,000
Q4 2019 Feb 11, 2020	SELL	$36.62 - $57.29 $5,712 - $8,937	-156 Reduced 52.35%	142 $31,000
Q3 2019 Nov 13, 2019	BUY	$35.53 - $43.8 $461 - $569	13 Added 4.56%	298 $44,000
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $4,343 - $6,071	156 Added 120.93%	285 $43,000
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $1,515 - $2,061	-54 Reduced 29.51%	129 $15,000
Q4 2018 Feb 13, 2019	SELL	$26.99 - $37.37 $2,510 - $3,475	-93 Reduced 33.7%	183 $22,000
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $747 - $1,175	-32 Reduced 10.39%	276 $39,000
Q2 2018 Aug 01, 2018	SELL	$17.54 - $25.22 $2,332 - $3,354	-133 Reduced 30.16%	308 $29,000
Q1 2018 May 16, 2018	SELL	$13.06 - $18.54 $130 - $185	-10 Reduced 2.22%	441 $33,000
Q4 2017 Feb 13, 2018	SELL	$11.12 - $15.38 $2,224 - $3,076	-200 Reduced 30.72%	451 $26,000
Q3 2017 Nov 08, 2017	BUY	$11.36 - $18.98 $2,237 - $3,739	197 Added 43.39%	651 $32,000
Q2 2017 Aug 15, 2017	BUY	N/A	392 Added 632.26%	454 $33,000
Q1 2017 Sep 15, 2017	SELL	N/A	-27 Reduced 30.34%	62 $5,000
Q4 2016 Sep 15, 2017	BUY	N/A	53 Added 147.22%	89 $5,000
Q3 2016 Sep 15, 2017	BUY	N/A	35 Added 3500.0%	36 $3,000
Q1 2016 Sep 15, 2017	SELL	N/A	-28 Reduced 96.55%	1 $0
Q4 2015 Sep 15, 2017	BUY	N/A	29	29 $2,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account